Product Information

BUPROPION HCL XL 150 MG TABLET is a generic product labeled by AvPAK, priced at $0.0787 per EA under NDC 50268013313. Its NADAC has been published 49 times since Sep 17, 2025.

FDA first approved this application on Apr 6, 2017. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUPROPION HCL XL 150 MG TABLET

Bupropion Hydrochloride
$0.0787per EA

Strength

150 mg/1

Manufacturer

AvPAK

NDC

50268013313

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

BUPROPION HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA090693

FDA Approved

4/6/2017

TE Code

AB3

On Market Since

3/5/2025

Pharmacological Classes

Aminoketone
Dopamine Uptake Inhibitors
Increased Dopamine Activity
Increased Norepinephrine Activity
Norepinephrine Uptake Inhibitors

Price Statistics

The NADAC for BUPROPION HCL XL 150 MG TABLET has been published 49 times since Sep 17, 2025, and over the history we have for it it has declined 21.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0787 per EA
All-time high$0.0996 (Oct 15, 2025)
All-time low$0.0770 (Apr 22, 2026)
52-week high$0.0996
52-week low$0.0770
Median price$0.0792
Average price$0.0848
Largest weekly change-8.4% (Feb 18, 2026)
Weeks tracked49
Tracking sinceSep 17, 2025

Price History

1W

+1.2%

1M

+1.1%

3M

-0.3%

6M

+0.2%

1Y

N/A

3Y

N/A

5Y

N/A

All

-21.0%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BUPROPION HCL XL 150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL XL 150 MG TABLET, manufactured by AvPAK, is $0.0787 per EA (NDC 50268013313), effective Aug 19, 2026.

How has the price of BUPROPION HCL XL 150 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUPROPION HCL XL 150 MG TABLET has declined 21.0%. It has been tracked across 49 weekly CMS publications since Sep 17, 2025.

What are the highest and lowest recorded NADAC prices for BUPROPION HCL XL 150 MG TABLET?

Since Sep 17, 2025, the NADAC for BUPROPION HCL XL 150 MG TABLET has ranged from a low of $0.0770 (Apr 22, 2026) to a high of $0.0996 (Oct 15, 2025), with a median of $0.0792 per EA.

Are there cheaper alternatives to BUPROPION HCL XL 150 MG TABLET?

10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPROPION HCL XL 150 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures BUPROPION HCL XL 150 MG TABLET?

BUPROPION HCL XL 150 MG TABLET (NDC 50268013313) is labeled by AvPAK, and CMS classifies it as a generic product.